Scinovex
article Open AccessTop 1% cited

Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

Clinical Cancer Research · 2004 · Vol. 10(16) · pp. 5367–5374
Torsten O. NielsenForrest D. HsuKristin C. JensenMaggie C.U. CheangGamze KaracaZhiyuan HuTina Hernandez‐BoussardChad LivasyDave CowanLynn G. DresslerLars A. AkslenJoseph RagazAllen M. GownC. Blake GilksMatt van de RijnCharles M. Perou

Abstract

A panel of four antibodies (ER, HER1, HER2, and cytokeratin 5/6) can accurately identify basal-like tumors using standard available clinical tools and shows high specificity. These studies show that many basal-like tumors express HER1, which suggests candidate drugs for evaluation in these patients.

Breast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchCancer and Skin LesionsCytokeratinTissue microarrayImmunohistochemistryBasal (medicine)Breast cancerPathologyBreast carcinomaEstrogen receptorBiologyEstrogen

MeSH terms

Breast NeoplasmsFemaleHumansImmunohistochemistryKeratinsNeoplasm InvasivenessReceptors, EstrogenBiomarkers, TumorSurvival AnalysisNeoplasms, Basal CellErb-b2 Receptor Tyrosine KinasesReceptor, ErbB-2Oligonucleotide Array Sequence Analysis

Funding

  • Michael Smith Health Research BC
  • University of North Carolina at Chapel Hill
  • National Cancer Institute
Citations
2,652
FWCI
44.30
field-weighted impact
References
27
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.